SynthesisClinical pharmacology and therapeutics2021

NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure.

Walter Schmitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.